CClinicalTrials.gg
CompletedNCT03270761Updated Jun 8, 2021

Zhongshan Iridocorneal Endothelial Syndrome Study (ICEs)

An observational study in Glaucoma, sponsored by Sun Yat-sen University. Completed at 1 site in China. Per ClinicalTrials.gov, last updated 2021-06-08.

Sponsored by Sun Yat-sen University · Observational

Study type
Observational
Model
Case-only
Time perspective
Cross-sectional
Enrollment
98
Sex
All
01

Study summary

This is a multi-center study to report the demographic profile, clinical features, and management in patients with Iridocorneal endothelial (ICE) syndrome in China.

02

Conditions studied

  • Glaucoma

Browse trials for

03

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

ICE syndrome patients identified and enrolled from 50 study centers in China.

Inclusion criteria

  • Clinical diagnosis of ICE syndrome;
  • Those willing to sign the informed consent.

Exclusion criteria

Exclusion Criteria:

  • Patients who don't sign the informed consent or abide by the study procedure.
04

Study design

Observational model
Case-only
Time perspective
Cross-sectional
Enrollment
98 participants (actual)
Target follow-up
1 Day
Patient registry
Yes
Biospecimen retention
Samples with dna
05

What researchers measure

Primary outcomes

  1. Management in patients with Iridocorneal endothelial (ICE) syndrome

    Record the number of medication treating corneal edema or glaucoma, and surgery (anti-glaucoma surgery, keratoplasty)

    Time frame: through study completion, an average of 1 year

Secondary outcomes

  1. Demographic profile of patients

    Range of age, gender

    Time frame: 1 day

06

Study locations

1 site
  • Zhongshan Ophthalmic Center
    Guangzhou, Guangdong 510060, China
07

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT03270761
Lead sponsor
Sun Yat-sen University
Collaborators
ICE study group
Responsible party
Xiulan Zhang (MD,PhD, Sun Yat-sen University) — Principal investigator
First posted
Sep 1, 2017
Start date
Sep 10, 2017
Primary completion
Dec 12, 2019
Completion
Dec 31, 2019
Last update
Jun 8, 2021

Study contacts

Xiulan Zhang, MD,PhD
principal investigator · Zhongshan Ophthalmic Center, Sun Yat-sen University

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion